[The use of delayed-action beta 1-24-corticotropin in the functional exploration of the adrenal cortex].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects; D000309:Adrenal Insufficiency / Q000188:drug therapy; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000494:pharmacology; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001623:Betamethasone / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007018:Hypopituitarism / Q000188:drug therapy; D007273:Injections, Intramuscular; D008297:Male; D008722:Methods; D008875:Middle Aged; D009765:Obesity / Q000652:urine; D010912:Pituitary-Adrenal Function Tests; D013268:Stimulation, Chemical; D013997:Time Factors
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003692:Delayed-Action Preparations; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D006854:Hydrocortisone
L'emploi de bêta 1-24 corticotrophine retard dans l'exploration fonctionnelle du cortex surrénal.